Design of small molecule ketoamide-based inhibitors of cathepsin K
John G Catalano1, David N Deaton, Stacey T Long
1Department of Medicinal Chemistry, GlaxoSmithKline, Research Triangle Park, NC 27709, USA.
Bioorganic & Medicinal Chemistry Letters
|January 27, 2004
Abstract:
A novel series of ketoamide-based inhibitors of cathepsin K has been identified. Modifications to P(2) and P(3) elements were crucial to enhancing inhibitory activity. Although not optimized, a selected inhibitor was effective in attenuating type I collagen hydrolysis in a surrogate assay of bone resorption.

